Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Aug 4, 2021, during market hours
10-Q filed Aug 4, 2021, 35 days after period end · 0000874015-21-000144
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $125.75M | $145.54M | $163.81M | $117.75M |
| Net Income | -$80.88M | -$25.64M | -$876.00K | -$40.36M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.57 |
| -$0.18 |
| -$0.01 |
| -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.